Emcure Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results
Emcure Pharmaceuticals Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Emcure Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results Emcure Pharmaceuticals Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve its standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities by designated persons and their relatives remains closed from 1st Oct'26 until 5th Nov'26 (48 hours post-earnings declaration) in compliance with SEBI insider trading regulations.
Original exchange filing (PDF)
More announcements from Emcure Pharmaceuticals Ltd
- Intimation of Cancellation of schedule of Analyst / Investor Meeting(s) scheduled on November 16, 2026 路 15 Nov 2026
- Transcript of Earnings Call - Q2 FY27 held on Tuesday, November 03, 2026 at 4:00 p.m. (IST) 路 06 Nov 2026
- Intimation of schedule of Analyst/Investor Meeting dated Monday, November 16, 2026 路 06 Nov 2026
- Intimation of schedule of Analyst/Investor Meeting on Monday, November 16, 2026 路 06 Nov 2026
- Audio recording of Earnings Call - Q2 FY27 路 04 Nov 2026
- Presentation on Unaudited Financial Results for the quarter ended September 30, 2026 路 03 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026 路 03 Nov 2026
- Emcure Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 03 Nov 2026
